Articles with public access mandates - Antonello MaiLearn more
OverallGovernment of ItalyNIHAIRC Foundation for Cancer Research in ItalyEuropean CommissionFondazione CariploINSERMNWOCancer Research UKDFGTelethonANRGovernment of SpainBBSRCMRCWellcomeWorldwide Cancer Research, UKDOEAHANHMRCCIHRFRQSGenome CanadaPCCFCTSwedish Research CouncilBHFEPSRCKWFCPRITFAPESPSNSFDoDVAHHMIFNRSFWOCCSNSFCBanking Foundation "la Caixa"Versus Arthritis, UKNIHRFNRSCLV Foundation, USALeducq Foundation, USARoyal Society UK
Not available anywhere: 32
Structural basis of sirtuin 6 activation by synthetic small molecules
W You, D Rotili, TM Li, C Kambach, M Meleshin, M Schutkowski, KF Chua, ...
Angewandte Chemie International Edition 56 (4), 1007-1011, 2017
Mandates: US National Institutes of Health, US Department of Veterans Affairs, German …
Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities
D Rotili, S Tomassi, M Conte, R Benedetti, M Tortorici, G Ciossani, ...
Journal of medicinal chemistry 57 (1), 42-55, 2014
Mandates: Fondazione Cariplo, Government of Italy
Sirtuin function in aging heart and vessels
C Cencioni, F Spallotta, A Mai, F Martelli, A Farsetti, AM Zeiher, ...
Journal of molecular and cellular cardiology 83, 55-61, 2015
Mandates: Fondazione Cariplo, Government of Italy
Lysine deacetylase inhibitors in parasites: past, present, and future perspectives
GS Hailu, D Robaa, M Forgione, W Sippl, D Rotili, A Mai
Journal of Medicinal Chemistry 60 (12), 4780-4804, 2017
Mandates: Fondazione Cariplo, European Commission, Government of Italy
Discovery of a novel inhibitor of histone lysine-specific demethylase 1A (KDM1A/LSD1) as orally active antitumor agent
P Vianello, OA Botrugno, A Cappa, R Dal Zuffo, P Dessanti, A Mai, ...
Journal of Medicinal Chemistry 59 (4), 1501-1517, 2016
Mandates: Fondazione Cariplo, Government of Italy
Emerging approaches for histone deacetylase inhibitor drug discovery
C Zwergel, S Valente, C Jacob, A Mai
Expert opinion on drug discovery 10 (6), 599-613, 2015
Mandates: Government of Italy
Non-Cancer Uses of Histone Deacetylase Inhibitors: Effects on Infectious Diseases and β-Hemoglobinopathies+
D Rotili, G Simonetti, A Savarino, AT Palamara, AR Migliaccio, A Mai
Current Topics in Medicinal Chemistry 9 (3), 272-291, 2009
Mandates: US National Institutes of Health
Chronic stress and antidepressant induced changes in Hdac5 and Sirt2 affect synaptic plasticity
M Erburu, I Muñoz-Cobo, J Domínguez-Andrés, E Beltran, T Suzuki, A Mai, ...
European Neuropsychopharmacology 25 (11), 2036-2048, 2015
Mandates: Government of Spain, Government of Italy
Sirtuin modulators: an updated patent review (2012–2014)
P Mellini, S Valente, A Mai
Expert opinion on therapeutic patents 25 (1), 5-15, 2015
Mandates: Government of Italy
Identification of novel quinazoline derivatives as potent antiplasmodial agents
A Bouchut, D Rotili, C Pierrot, S Valente, S Lafitte, J Schultz, U Hoglund, ...
European Journal of Medicinal Chemistry 161, 277-291, 2019
Mandates: US National Institutes of Health, National Health and Medical Research …
Sirtuin modulators: where are we now? A review of patents from 2015 to 2019
N Mautone, C Zwergel, A Mai, D Rotili
Expert Opinion on Therapeutic Patents 30 (6), 389-407, 2020
Mandates: US National Institutes of Health, Government of Italy, AIRC Foundation for …
Targeting histone acetylation/deacetylation in parasites: an update (2017–2020)
R Fioravanti, N Mautone, A Rovere, D Rotili, A Mai
Current Opinion in Chemical Biology 57, 65-74, 2020
Mandates: Government of Italy, AIRC Foundation for Cancer Research in Italy
MC1568 inhibits HDAC6/8 activity and influenza A virus replication in lung epithelial cells: role of Hsp90 acetylation
S Panella, ME Marcocci, I Celestino, S Valente, C Zwergel, DD Li Puma, ...
Future medicinal chemistry 8 (17), 2017-2031, 2016
Mandates: Government of Italy
Histone deacetylases as an epigenetic pillar for the development of hybrid inhibitors in cancer
G Stazi, R Fioravanti, A Mai, A Mattevi, S Valente
Current opinion in chemical biology 50, 89-100, 2019
Mandates: Government of Italy
Lysine acetyltransferase inhibitors: structure–activity relationships and potential therapeutic implications
F Fiorentino, A Mai, D Rotili
Future Medicinal Chemistry 10 (9), 1067-1091, 2018
Mandates: European Commission, Government of Italy
Histone deacetylases contribute to excitotoxicity-triggered degeneration of retinal ganglion cells in vivo
A Schlüter, B Aksan, R Fioravanti, S Valente, A Mai, D Mauceri
Molecular neurobiology 56, 8018-8034, 2019
Mandates: German Research Foundation, Government of Italy, AIRC Foundation for Cancer …
Acute and chronic neurobehavioral effects of the designer drug and bath salt constituent 3, 4-methylenedioxypyrovalerone in the rat
LA Atehortua-Martinez, C Masniere, P Campolongo, S Chasseigneaux, ...
Journal of Psychopharmacology 33 (3), 392-405, 2019
Mandates: National Institute of Health and Medical Research, France
Effect of Class II HDAC inhibition on glutamate transporter expression and survival in SOD1-ALS mice
A Lapucci, L Cavone, D Buonvicino, R Felici, E Gerace, C Zwergel, ...
Neuroscience Letters 656, 120-125, 2017
Mandates: Government of Italy
Altered mitochondrial function in cells carrying a premutation or unmethylated full mutation of the FMR1 gene
V Nobile, F Palumbo, S Lanni, V Ghisio, A Vitali, M Castagnola, ...
Human Genetics 139, 227-245, 2020
Mandates: Fondazione Telethon, Italy, Government of Italy
Epigenetic metalloenzymes
C Blanquart, C Linot, PF Cartron, D Tomaselli, A Mai, P Bertrand
Current Medicinal Chemistry 26 (15), 2748-2785, 2019
Mandates: US National Institutes of Health, European Commission, Swiss Cancer League …
Publication and funding information is determined automatically by a computer program